Literature DB >> 16356861

The juxtamembrane wedge negatively regulates CD45 function in B cells.

Michelle L Hermiston1, Allison L Tan, Vikas A Gupta, Ravindra Majeti, Arthur Weiss.   

Abstract

CD45 is a receptor-like protein tyrosine phosphatase highly expressed on all nucleated hematopoietic cells. We previously generated mice containing a point mutation in the juxtamembrane wedge of CD45. Demonstrating the critical negative regulatory function of the wedge, the CD45 E613R mutation led to a lymphoproliferative disorder (LPD) and a lupus-like autoimmune syndrome. Here we show the central role of B cells in this phenotype. Genetic elimination of B cells, but not T cells, ablates the LPD. In contrast to CD45-deficient B cells, the E613R mutation generates hyperresponsive B cells. Comparison of CD45-deficient and CD45 E613R mice reveals dichotomous effects of these mutations on B cell development. Together, the results support a role for CD45 as a rheostat, with both positive and negative regulatory functions, that fine-tunes the signal transduction threshold at multiple checkpoints in B cell development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356861     DOI: 10.1016/j.immuni.2005.11.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  27 in total

1.  Multistoried roles for B lymphocytes in autoimmunity.

Authors:  Masaki Hikada; Moncef Zouali
Journal:  Nat Immunol       Date:  2010-12       Impact factor: 25.606

2.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

3.  Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses.

Authors:  Michelle L Hermiston; Julie Zikherman; Allison L Tan; Viola C Lam; Nicole M Cresalia; Nir Oksenberg; Nira Goren; David Brassat; Jorge R Oksenberg; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

4.  The receptor protein tyrosine phosphatase LAR promotes R7 photoreceptor axon targeting by a phosphatase-independent signaling mechanism.

Authors:  Kerstin Hofmeyer; Jessica E Treisman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

Review 5.  Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.

Authors:  Stephanie M Stanford; Tomas M Mustelin; Nunzio Bottini
Journal:  Semin Immunopathol       Date:  2010-03-04       Impact factor: 9.623

6.  IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Authors:  Byron B Au-Yeung; Geoffrey Alexander Smith; James L Mueller; Cheryl S Heyn; Rebecca Garrett Jaszczak; Arthur Weiss; Julie Zikherman
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 7.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

8.  Unbiased modifier screen reveals that signal strength determines the regulatory role murine TLR9 plays in autoantibody production.

Authors:  Robyn E Mills; Viola C Lam; Allison Tan; Nicole Cresalia; Nir Oksenberg; Julie Zikherman; Mark Anderson; Arthur Weiss; Michelle L Hermiston
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

9.  PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.

Authors:  Julie Zikherman; Michelle Hermiston; David Steiner; Kiminori Hasegawa; Andrew Chan; Arthur Weiss
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 10.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.